首页|Transepithelial leak in Barrett's esophagus patients: The role of proton pump inhibitors
Transepithelial leak in Barrett's esophagus patients: The role of proton pump inhibitors
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
维普
AIM:To determine if the observed paracellular sucrose leak in Barrett's esophagus patients is due to their proton pump inhibitor (PPI) use.METHODS:The in vivo sucrose permeability test was administered to healthy controls,to Barrett's patients and to non-Barrett's patients on continuous PPI therapy.Degree of leak was tested for correlation with presence of Barrett's,use of PPIs,and length of Barrett's segment and duration of PPI use.RESULTS:Barrett's patients manifested a near 3-fold greater,upper gastrointestinal sucrose leak than healthy controls.A decrease of sucrose leak was observed in Barrett's patients who ceased PPI use for 7 d.Although initial introduction of PPI use (in a PPI-nafve population) results in dramatic increase in sucrose leak,long-term,continuous PPI use manifested a slow spontaneous decline in leak.The sucrose leak observed in Barrett's patients showed no correlation to the amount of Barrett's tissue present in the esophagus.CONCLUSION:Although future research is needed to determine the degree of paracellular leak in actual Barrett's mucosa,the relatively high degree of leak observed with in vivo sucrose permeability measurement of Barrett's patients reflects their PPI use and not their Barrett's tissue per se.
Christopher Farrell、Melissa Morgan、Owen Tully、Kevin Wolov、Keith Kearney、Benjamin Ngo、Giancarlo Mercogliano,、James J Thornton、Mary Carmen Valenzano、James M Mullin
展开 >
Division of Gastroenterology, Lankenau Hospital, Wynnewood, PA 19096, United States
Lankenau Institute for Medical Research, Wynnewood, PA 19096, United States
NETL
NSTL
万方数据
维普
